We collected testes biopsies from NOA (severe spermatogenic defects, no spermatids or sperm) and OA (normal spermatogenesis, tubular lumen obstruction) patients for iTRAQ proteomics analyses, to screen the genes for which the altered expression is involved in spermatogenic defects